学术报告题目：Structure-Based Drug Design and Discovery of Phosphodiesterase ...
2017-04-25
Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, USA
时间：2017年4月28日（星期五）上午10:30
地点：第六教学楼 222会议室
报告人简介：
Prof Hengming Ke (Research Field: X-ray Protein Crystallography and Biochemistry)
1976: B.S. from Zhongshan University
1989: Ph.D. from Harvard University
1990-2000: Associate Professor, University of North Carolina at Chapel Hill
2001-Present: Professor, University of North Carolina at Chapel Hill
His research focuses on the structure and function of medically important proteins, and structure-based design of inhibitors for treatment of human diseases. The current topics include enzymatic and structural characterization of cyclic nucleotide phosphodiesterases (PDEs), structure-based design of PDE selective inhibitors, and discovery of novel metallo-β-lactamase (MBL) inhibitors to fight against superbugs.
Group Page: http://www.med.unc.edu/biochem/people/faculty/primary/ke
当天下午（1:00至4:00）有意愿单独交流的老师请联系叶萌春（13072287038）
手机扫描二维码
关注“南开化学”微信公众号
关注“南开化学”微信公众号
版权所有：新葡的京集团3512vip(中国)股份公司版权所有